It is shown that, under certain assumptions, one can estimate the difference between the effect of a treatment and that of a placebo even when the treatment has been given to all and only those patients who are at risk (as evidenced by a screening examination).
= JU(X4)dx (~p(x) = (2ir) -2exp(-x2/2))
A new drug is to be tested for its effect on, say, hypertension. For a patient randomly chosen from some population let 6 = the patient's "true" (unobservable) blood pressure x = the patient's blood pressure reading obtained at a screening examination before any treatment is undertaken.
We shall assume that given 6, x is N(6, ac2), where o is a constant, known or unknown. We make no assumption about how 6 is distributed in the population.
Suppose that if x > a the patient is regarded as at risk. A standard method for evaluating the new drug is to allocate randomly half of all such patients to the new drug and half to a placebo. Suppose, however, that for ethical or other reasons we have adopted the following allocation protocol: {if x > a, the patient is treated with the drug if x c a, the patient is treated with a placebo.
Let y = the blood pressure reading of the patient after treatment.
From the observed values (xj, yj), . . *, (xn, Yn) for n tients, we want to estimate the parameter T = mean effect of the drug, as compared to the plac over the population at risk (x > a).
It is not clear a priori that a consistent estimator of T be found under the allocation protocol (A), but in the sec below we shall show how to do this under an assumptio below) concerning y.
Consistent Estimation of r. LEMMA. Assume that (6, x) random vector such that for some constant o > 0, given 6, x is N(6, ar2).
If u( ) is of bounded variation (b.v.) and absolutely conti ous (a.c.) on (-00, 00), then (-a:o, oo) , then
Proof. By assumption 3,
which was to be proved. [1] Setting u = 1 in formula 4 gives the following. COROLLARY 1. Under assumptions 1 and 3, E[a(x)t(6, x)] = E(y -x) -c.
[5] [2] We shall also need the following. U2(-) are b.v. and a.c. on (-oo, om) and vanish for x > a, then
and hence
provided that the denominator is not 0. We now define the parameter T by
(by formula 5).
E,6a(x) [8] (In the case of hypertension we hope that t, and hence T, is negative.) We can estimate c and r by provided that u1( ) is b.v. and a.c., vanishes for x > a, and Eul(x) + 0. Remark 3. An inspection of the proofs shows that all the foregoing formulas remain valid even if the b.v. functions u( ) occurring in formulas 2, 4, 6, and 7 are not a.c., provided that we always replace Eu'(x) by ff(x)du(x), [13] where f(*) is the probability density function of the random variable x. In particular, choosing uA(x) = 1 -8a(X), u2(x) = 1 -8b(x) for some b < a, [14] we obtain the formulas
which can be used when o-is known or unknown to estimate c (and hence r), provided that we have consistent density estimators f(a), fn(b) of f(a) and f(b). Such estimators are available, and have an n-1/2 rate of convergence, if we make [9] the additional assumption that for some a and , > 0, 6 is N(a, p2).
[16]
For then x will (from assumption 1) be N(a, y2) with y2 = p2 + cr2, and hence [10] where by hypothesis (6, x, y), (6,1, Xil yj), . . . are independent, identically distributed random vectors such that assumptions 1 and 3 hold. It is clear from formulas 7-10 that the following theorem holds. THEOREM 2. As n -0, Remark 1. The functions u1i() and u2( ) in formulas 6, 7, and 9 are assumed to be b.v. and a.c., vanishing for x > a, and such that the denominator of formula 7 is not 0. Subject to these restrictions, they are arbitrary. We do not know how to choose them so as to minimize the limiting variance of V'n(cn-c) or V\n(r, -r). to obtain consistent estimators of c with n1in rates of convergence. It would, however, be safer to use formula 9 or 11 instead of formula 20 or 19 if it is not certain that 6 is in fact normally distributed. Remark 4. From formula 8 and the first part of formula 15 it follows that
Thus, under (A), the statistic (average of yi -xi for those treated with drug) - (average of yi -xi for those treated with placebo) [21] converges as n --00 to a-2f(a) T~-P(x > a) * P(x c a)' which is less than T, so that even if t and hence r is 0 the value of the statistic 21 will usually be negative.
Remark 5. If we replace the unknown constant in assumption 3 by any linear combination Clgl(X) + . . * + Ckgk(X) [22] of known functions with unknown coefficients cl, . . ., Ck, then it is clear how to generalize formulas 6 and 9 to estimate these coefficients by using functions uj(x),j = 1,. . ., k + 1.
Remark 6. When in assumption 3 the function t(6, x) is a constant and y, given 6 and x, is N(6 + c + 8a(x) * t, a.2), the method of conditional maximum likelihood can be used to estimate t, as by Robbins and Zhang (1). There are some technical difficulties in the present case, and we defer a comparison with the method for consistent estimation of r described above to a later date.
